Assembly Biosciences
ASMB
35 hedge funds and large institutions have $50.3M invested in Assembly Biosciences in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 5 closing their positions.
718% more capital inflows, than outflows
Capital inflows: $39.7M | Capital outflows: $4.86M
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
57% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 7
33.92% more ownership
Funds ownership: 16.17% → 50.09% (+34%)
17% more funds holding
Funds holding: 30 → 35 (+5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$468K |
| 2 |
Man Group
London,
United Kingdom
|
+$315K |
| 3 |
PWM
Palumbo Wealth Management
Great Neck,
New York
|
+$184K |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$174K |
| 5 |
JP Morgan Chase
New York
|
+$127K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Armistice Capital
New York
|
-$2.99M |
| 2 |
AI
Acuitas Investments
Seattle,
Washington
|
-$943K |
| 3 |
Millennium Management
New York
|
-$569K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$193K |
| 5 |
Amundi
Paris,
France
|
-$114K |
ASMB Hedge Fund Activity: Q4 2024 in Review
35 of the 7,615 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q4 2024, worth a combined $50.3M — up 223% from $15.5M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ASMB positions and 5 closed out — a net gain of 5 holders — while 11 added to existing stakes and 7 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $468K. The largest seller was Armistice Capital, cutting an estimated $2.99M.
- 35 institutional investors held Assembly Biosciences (ASMB) as of Q4 2024, up from 30 in Q3 2024.
- Funds reported $50.3M of Assembly Biosciences stock for Q4 2024, up 223% quarter-over-quarter.
- 10 funds opened new Assembly Biosciences positions in Q4 2024 and 5 closed out, a net change of +5 holders.
- The largest Assembly Biosciences buyer in Q4 2024 was Renaissance Technologies, an estimated $468K added.
- The largest Assembly Biosciences seller in Q4 2024 was Armistice Capital, an estimated $2.99M sold.
Based on aggregated 13F filings for Q4 2024.